Sage Therapeutics, Inc.
USD8.68
+0.00 (+0.00%)
CEO
Barry E. Greene
IPO Date
2014-07-18
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$8.68
Prev. Close
$8.68
Day Low
$8.68
Day High
$8.68
52W Low
$4.62
52W High
$9.36
Market Cap
$0.54B
Volume
17.39M
| -2.4 |
| 31 Dec 2022 | FY | 89.4% | -6547.8% | -40.2% | -37.1% | 0.01 | 12.82 | -4.5 |
| 31 Dec 2021 | FY | 91.2% | -7146.9% | -26.1% | -24.7% | 0.01 | 21.14 | -5.5 |
| 31 Dec 2020 | FY | 99.9% | 54.4% | 29.2% | 28.1% | 0.01 | 31.58 | 7.4 |
| 31 Dec 2019 | FY | 94.2% | -9466.4% | -68.8% | -60.0% | 0.04 | 9.23 | -5.6 |
| 31 Dec 2018 | FY | 98.8% | -413.1% | -43.2% | -39.1% | 0.00 | 10.98 | -11.8 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -56.8% | -51.0% | 0.00 | 10.11 | -23.2 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -43.1% | -39.3% | 0.00 | 11.45 | -10.7 |
| 31 Dec 2015 | FY | 0.0% | 0.0% | -54.4% | -50.0% | 0.00 | 12.31 | -17.1 |
| -2.0 |
| 31 Dec 2024 | Q4 | 88.4% | -747.3% | -20.6% | -17.5% | 0.03 | 7.42 | -0.9 |
| 30 Sept 2024 | Q3 | 55.5% | -788.1% | -17.0% | -15.0% | 0.02 | 10.02 | -1.2 |
| 30 Jun 2024 | Q2 | 83.7% | -1188.5% | -16.4% | -14.8% | 0.00 | 9.95 | -1.6 |
| 31 Mar 2024 | Q1 | 83.9% | -1372.9% | -15.4% | -14.1% | 0.00 | 12.22 | -2.5 |
| 31 Dec 2023 | Q4 | 98.9% | -41.9% | -4.1% | -3.7% | 0.01 | 10.51 | -9.9 |
| 30 Sept 2023 | Q3 | 66.7% | -7423.8% | -24.7% | -21.2% | 0.01 | 7.02 | -1.5 |
| 30 Jun 2023 | Q2 | 91.7% | -6480.4% | -16.3% | -14.8% | 0.01 | 10.36 | -4.4 |
| 31 Mar 2023 | Q1 | 93.0% | -4195.1% | -12.2% | -11.3% | 0.01 | 14.21 | -4.5 |